Elevance Health (ELV) Cost of Revenue (2009 - 2026)

Elevance Health (ELV) has 18 years of Cost of Revenue data on file, last reported at $35.6 billion in Q1 2026.

• Quarterly Cost of Revenue rose 614.73% year-over-year to $35.6 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $84.6 billion (up 242.32% YoY) and the FY2025 annual result came in at $21.2 billion, up 7.23% from the prior year.
• Cost of Revenue advanced to $35.6 billion in Q1 2026 per ELV's latest filing, from $5.5 billion in the prior quarter.
• Across five years, Cost of Revenue topped out at $111.9 billion in Q4 2023 and bottomed at -$74.3 billion in Q4 2024.
• The 5-year median for Cost of Revenue is $5.1 billion (2024), against an average of $14.3 billion.
• The widest annual swing landed in 2023, when Cost of Revenue surged 2968.4%; it then tumbled 166.43% in 2024.
• Tracing ELV's Cost of Revenue over 5 years: stood at $3.6 billion in 2022, then surged by 2968.4% to $111.9 billion in 2023, then plunged by 166.43% to -$74.3 billion in 2024, then jumped by 107.43% to $5.5 billion in 2025, then soared by 544.97% to $35.6 billion in 2026.
• Per Business Quant, the three latest ELV Cost of Revenue figures stand at $35.6 billion (Q1 2026), $5.5 billion (Q4 2025), and $38.1 billion (Q3 2025).

Peer Comparison